BioVie Inc.
BioVie Inc. (BIVI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bivi · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BioVie Inc. (BIVI) measures how much investors pay for each dollar of the company's trailing earnings. BIVI's current PE ratio of N/A is calculated by dividing its stock price of $1.67 by its TTM earnings per share of -$2.64.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BioVie Inc.You BIVI | $13M | N/A | — | -$2.64 |
 Artelo Biosciences, Inc. ARTL | $3M | N/A | — | -$5.47 |
 Can-Fite BioPharma Ltd. CANF | $2M | N/A | — | -$12.02 |
 CERo Therapeutics Holdings, Inc. CERO | $0M | N/A | — | -$4.71 |
 PMGC Holdings Inc. ELAB | $3M | N/A | — | -$378.74 |
 Galmed Pharmaceuticals Ltd. GLMD | $3M | N/A | — | -$2.39 |
 InMed Pharmaceuticals Inc. INM | $3M | N/A | — | -$8.36 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-11.87 | — | |
2024-06-30 FY2024 | — | $-71.09 | — | |
2023-06-30 FY2023 | — | $-154.71 | — | |
2022-06-30 FY2022 | — | $-105.77 | — | |
2021-06-30 FY2021 | — | $-1050.13 | — | |
2020-06-30 FY2020 | — | $-338.31 | — | |
2019-06-30 FY2019 | — | $-98.15 | — | |
2018-06-30 FY2018 | — | $-321.73 | — | |
2017-06-30 FY2017 | — | $-187.46 | — | |
2016-06-30 FY2016 | — | $-62.60 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BioVie Inc. (BIVI) measures how much investors pay for each dollar of the company's trailing earnings. BIVI's current PE ratio of N/A is calculated by dividing its stock price of $1.67 by its TTM earnings per share of -$2.64.
Frequently asked questions
BIVI pe ratio · 6 questionsBIVI's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.67 and TTM EPS of -$2.64. Data sourced from Financial Modeling Prep via BIVI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioVie Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08